M. Hale

1.9k total citations
46 papers, 1.5k citations indexed

About

M. Hale is a scholar working on Anesthesiology and Pain Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, M. Hale has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Anesthesiology and Pain Medicine, 24 papers in Physiology and 20 papers in Public Health, Environmental and Occupational Health. Recurrent topics in M. Hale's work include Pain Management and Opioid Use (27 papers), Pain Mechanisms and Treatments (24 papers) and Opioid Use Disorder Treatment (20 papers). M. Hale is often cited by papers focused on Pain Management and Opioid Use (27 papers), Pain Mechanisms and Treatments (24 papers) and Opioid Use Disorder Treatment (20 papers). M. Hale collaborates with scholars based in United States, Australia and Belgium. M. Hale's co-authors include Joseph Gimbel, Richard Rauck, James Wild, Chris Dvergsten, Peter G. Lacouture, Harry Ahdieh, Tina Ma, Tadaaki Yamada, Joshua Caldwell and Juan Camilo Arjona Ferreira and has published in prestigious journals such as Gastroenterology, Pain and The American Journal of Gastroenterology.

In The Last Decade

M. Hale

45 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Hale United States	19	856	628	612	529	351	46	1.5k
Christine Rauschkolb United States	15	693 0.8×	460 0.7×	875 1.4×	730 1.4×	396 1.1×	26	1.7k
L. Allan United Kingdom	11	588 0.7×	374 0.6×	335 0.5×	291 0.6×	153 0.4×	15	927
Bernd Lange Germany	13	430 0.5×	342 0.5×	662 1.1×	401 0.8×	180 0.5×	33	1.1k
Achim Steup Germany	12	487 0.6×	355 0.6×	530 0.9×	361 0.7×	255 0.7×	34	995
Luis Enrique Chaparro Canada	12	578 0.7×	323 0.5×	407 0.7×	521 1.0×	601 1.7×	26	1.5k
M. Strumpf Germany	12	733 0.9×	322 0.5×	360 0.6×	196 0.4×	201 0.6×	55	1.0k
Gerhard Müller-Schwefe Germany	17	429 0.5×	210 0.3×	381 0.6×	513 1.0×	157 0.4×	61	1.2k
Petra Leyendecker Germany	13	613 0.7×	234 0.4×	291 0.5×	117 0.2×	594 1.7×	16	1.3k
P. Richards United States	12	417 0.5×	220 0.4×	480 0.8×	202 0.4×	168 0.5×	26	856
Keith Budd United Kingdom	13	621 0.7×	396 0.6×	380 0.6×	190 0.4×	192 0.5×	30	1.1k

Countries citing papers authored by M. Hale

Since Specialization

Citations

This map shows the geographic impact of M. Hale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hale more than expected).

Fields of papers citing papers by M. Hale

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hale. The network helps show where M. Hale may publish in the future.

Co-authorship network of co-authors of M. Hale

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hale. A scholar is included among the top collaborators of M. Hale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hale. M. Hale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tack, Jan, Michael Camilleri, M. Hale, et al.. (2021). Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation. Clinical Gastroenterology and Hepatology. 20(4). 855–863. 9 indexed citations

Hale, M., James Wild, Tadaaki Yamada, et al.. (2021). Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives. Therapeutic Advances in Gastroenterology. 14. 1088215296–1088215296. 2 indexed citations

Camilleri, Michael, M. Hale, Bart Morlion, et al.. (2021). Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies. Journal of Pain Research. Volume 14. 2179–2189. 6 indexed citations

Hale, M., et al.. (2021). Benefit-Risk Analysis of Buprenorphine for Pain Management. Journal of Pain Research. Volume 14. 1359–1369. 31 indexed citations

Webster, Lynn R., M. Hale, Tadaaki Yamada, & James Wild. (2020). <p>A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy</p>. Journal of Pain Research. Volume 13. 605–612. 7 indexed citations

Wild, James, Lynn R. Webster, Tadaaki Yamada, & M. Hale. (2020). Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age. Drugs & Aging. 37(4). 271–279. 16 indexed citations

Hale, M., et al.. (2017). Long-term safety and analgesic efficacy of buprenorphine buccal film in patients with moderate-to-severe chronic pain requiring around-the-clock opioids. Journal of Pain Research. Volume 10. 233–240. 22 indexed citations

Hale, M., Yuju Ma, & Richard Malamut. (2016). Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential. Journal of Opioid Management. 12(2). 139–147. 7 indexed citations

Hale, M., Thomas Zimmerman, Eli Eyal, & Richard Malamut. (2015). Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain. Journal of Opioid Management. 11(6). 507–518. 14 indexed citations

10.

Hale, M., Charles Laudadio, Ronghua Yang, Arvind Narayana, & Richard Malamut. (2015). Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain. Journal of Pain Research. 8. 623–623. 10 indexed citations

11.

Hale, M., Thomas Zimmerman, Yuju Ma, & Richard Malamut. (2015). Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain. Journal of Opioid Management. 11(5). 425–434. 6 indexed citations

12.

Singla, Neil, M. Hale, Jeffrey C. Davis, et al.. (2014). IV Acetaminophen. American Journal of Therapeutics. 22(1). 2–10. 33 indexed citations

13.

Nalamachu, Srinivas, et al.. (2014). A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain. Journal of Pain Research. 7. 669–669. 11 indexed citations

14.

Nalamachu, Srinivas, et al.. (2012). Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer Pain: Pooled Analysis of 11 Clinical Studies. Journal of Pain and Symptom Management. 44(6). 852–865. 11 indexed citations

15.

Hale, M., et al.. (2012). Safety and tolerability of OROS® hydromorphone ER in adults with chronic noncancer and cancer pain: Pooled analysis of 13 studies. Journal of Opioid Management. 8(5). 299–314. 2 indexed citations

16.

Steiner, Deborah, et al.. (2009). The efficacy and safety of buprenorphine transdermal system (BTDS) in subjects with moderate to severe low back pain: a double-blind study. Journal of Pain. 10(4). S51–S51. 5 indexed citations

17.

Hale, M., Iulia Cristina Tudor, Sarita Khanna, & John Thipphawong. (2007). Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis. Clinical Therapeutics. 29(5). 874–888. 68 indexed citations

18.

Gimbel, Joseph, Richard T. Linn, M. Hale, & Bruce Nicholson. (2005). Lidocaine Patch Treatment in Patients with Low Back Pain: Results of an Open-Label, Nonrandomized Pilot Study. American Journal of Therapeutics. 12(4). 311–319. 80 indexed citations

19.

Hale, M., Roy Fleischmann, Robert T. Salzman, et al.. (1999). Efficacy and Safety of Controlled-Release Versus Immediate-Release Oxycodone: Randomized, Double-Blind Evaluation in Patients with Chronic Back Pain. Clinical Journal of Pain. 15(3). 179–183. 105 indexed citations

20.

Segal, I, et al.. (1989). The Prolonged Course of Gastrointestinal Tuberculosis. Journal of Clinical Gastroenterology. 11(6). 671–674. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact